Table 1.
Age-standardised rate (ASR) and estimated annual percentage change of gastric cancer by anatomical subsite and race, SEER9 registries, 1976–2007
| Anatomical subsite | Race | ASR (25–84 years) | Age groups
|
|||
|---|---|---|---|---|---|---|
| 25–39 years EAPC (95% CI) |
40–59 years EAPC (95% CI) |
60–84 years EAPC (95% CI) |
25–84 years EAPC (95% CI) |
|||
| C16.0-Cardia | Whites | 3.3 | 1.8 (0.1 to 3.5) | −0.1 (−1.1 to 0. 8) | 1.2 (0.3 to 2.0) | 0.8 (0.0 to 1.6) |
| Blacks | 2.0 | 0.8* (−5.4 to 7.4) | −0.4 (−2.1 to 1.4) | 0.5 (−1.3 to 2.2) | 0.2 (−1.2 to 1.8) | |
| Others | 2.4 | 1.1* (−3.0 to 5.2) | 0.4* (−1.2 to 1.9) | 0.2 (0.0 to 0.5) | 0.3 (0.0 to 0.7) | |
| C16.1-Fundus | Whites | 0.5 | 0.8* (−1.5 to 3.3) | −0.9 (−2.6 to 0.8) | −2.8 (−3.6 to −1.9) | −2.3 (−3.1 to −1.5) |
| Blacks | 0.9 | – | −1.2* (−3.5 to 1.3) | −0.8 (−2.4 to 0.8) | −0.8 (−2.3 to 0.7) | |
| Others | 0.7 | – | −3.0* (−5.6 to −0.4) | −3.4* (−6.0 to −0.8) | −3.3 (−5.5 to −1.0) | |
| C16.2-Corpus | Whites | 0.6 | 3.2* (−1.5 to 8.1) | 2.1 (0.8 to 3.4) | 0.7 (−0.5 to 2.0) | 1.0 (0.1 to 1.9) |
| Blacks | 1.4 | 6.2* (2.2 to 10.5) | 2.9* (0.7 to 5.1) | 3.5* (1.6 to 5.5) | 3.5 (1.8 to 5.2) | |
| Others | 2.2 | −3.2* (−7.1 to 0.8) | −4.9* (−6.7 to −3.0) | −1.7 (−3.1 to −0.2) | −2.4 (−3.7 to −1.1) | |
| C16.3-Antrum | Whites | 1.6 | 4.4* (1.8 to 7.1) | −1.6 (−2.6 to −0.7) | −2.5 (−3.2 to −1.8) | −2.3 (−2.9 to −1.7) |
| Blacks | 4.6 | −1.1* (−4.4 to 2.4) | −2.7 (−4.1 to −1.3) | −1.9 (−2.9 to −1.0) | −2.1 (−2.8 to −1.3) | |
| Others | 6.3 | −0.6* (−4.7 to 3.7) | −2.7 (−4.2 to −1.2) | −2.4 (−3.2 to −1.5) | −2.4 (−3.2 to −1.6) | |
| C16.4-Pylorus | Whites | 0.3 | – | −4.4* (−6.5 to −2.2) | −3.6 (−4.2 to −3.0) | −3.8 (−4.5 to −3.1) |
| Blacks | 0.9 | – | −1.7* (−5.3 to 2.0) | −1.7 (−4.3 to 1.0) | −1.8 (−4.0 to 0.4) | |
| Others | 0.7 | – | −5.0* (−7.5 to −2.5) | −2.3* (−4.9 to 0.3) | −2.9 (−5.0 to −0.8) | |
| C16.5-Lesser curvature | Whites | 1.0 | −1.8* (−4.7 to 1.2) | −3.9 (−5.4 to −2.4) | −3.4 (−4.2 to −2.7) | −3.5 (−4.1 to −2.9) |
| Blacks | 2.5 | −1.1* (−6.0 to 4.1) | −4.5 (−6.5 to −2.4) | −3.3 (−4.7 to −1.8) | −3.5 (−5.0 to −1.9) | |
| Others | 2.9 | −2.6* (−6.4 to 1.3) | −2.9 (−5.0 to −0.8) | −1.6 (−3.6 to 0.4) | −1.9 (−3.6 to −0.1) | |
| C16.6-Greater curvature | Whites | 0.5 | −2.3* (−6.7 | to− 2.3) 2.0 (−3.7 to −0.2) | −2.8 (−3.2 to −2.3) | −2.6 (−3.0 to −2.2) |
| Blacks | 1.0 | −3.8* (−8.5 to 1.0) | −2.4* (−4.4 to −0.3) | −3.0 (−4.3 to −1.7) | −2.9 (−3.9 to −1.9) | |
| Others | 1.2 | – | −2.4* (−4.9 to 0.2) | −0.8* (−3.7 to 2.1) | −1.2 (−3.6 to 1.4) | |
| C16.8-Overlapping lesion | Whites | 1.0 | −1.1* (−3.3 to 1.3) | −3.8 (−4.6 to −3.0) | −4.6 (−5.7 to −3.4) | −4.3 (−5.3 to −3.4) |
| Blacks | 2.2 | −0.7* (−5.2 to 4.0) | −3.3 (−4.9 to −1.6) | −3.5 (−4.4 to −2.5) | −3.3 (−3.9 to −2.7) | |
| Others | 2.9 | −5.7* (−7.6 to −3.7) | −5.4 (−7.7 to −3.0) | −5.2 (−7.6 to −2.8) | −5.3 (−7.3 to −3.3) | |
| C16.9-Not otherwise specified | Whites | 2.4 | 0.0 (−3.9 to 4.1) | −2.7 (−3.8 to −1.6) | −3.5 (−4.5 to −2.6) | −3.3 (−4.3 to −2.2) |
| Blacks | 4.5 | 0.3* (−2.0 to 2.6) | −1.4 (−2.4 to −0.4) | −1.6 (−2.5 to −0.7) | −1.5 (−2.3 to −0.8) | |
| Others | 3.7 | −1.4* (−5.0 to 2.4) | −2.1 (−3.4 to −0.8) | −3.0 (−3.9 to −2.1) | −2.7 (−3.5 to −2.0) | |
*
Estimates based on <16 cancer cases for at least one 4-year period.
EAPC, estimated annual percentage change; SEER, Surveillance, Epidemiology, and End Results.